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pyruvate plays a Main Role in 
the Antitumoral selectivity of 
Cold Atmospheric plasma in 
osteosarcoma
Juan tornin1,2, Miguel Mateu-sanz1,2, Aida Rodríguez3, Cédric Labay1,2, Rene Rodríguez3,4,5 & 
Cristina Canal  1,2
osteosarcoma (os) is the most common primary bone tumor but current therapies still have poor 
prognosis. Cold Atmospheric Plasma (CAP) and Plasma activated media (PAM) have shown potential 
to eliminate cancer cells in other tumors. It is thought that Reactive Oxygen and Nitrogen species 
(RONS) in PAM are key players but cell culture media composition alters treatment outcomes and data 
interpretation due to scavenging of certain RONS. In this work, an atmospheric pressure plasma jet 
was employed to obtain PAM in the presence or absence of pyruvate and used to treat the SaOS-2 (OS) 
cell line or hBM-MSC healthy cells. OS cells show higher sensitivity to PAM treatment than healthy 
cells, both in medium with and without pyruvate, activating apoptosis, DNA damage and deregulating 
cellular pathways mediated by c-JUN, AKT, AMPK or STAT3. In line with previous works, lack of 
pyruvate increases cytotoxic potential of PAM affecting cancer and healthy cells by increasing 10–100 
times the concentration of H2o2 without altering that of nitrites and thus decreasing CAP anti-tumor 
selectivity. Suitable conditions for CAP anti-cancer selectivity can be obtained by modifying plasma 
process parameters (distance, flow, treatment time) to obtain adequate balance of the different RONS 
in cell culture media.
Osteosarcoma is the most common primary bone tumor and accounts for approximately 19% of all malignant 
tumors in bone and 40–60% of all primary malignant tumors of bone1,2. Despite being rare, it is the most common 
solid tumor in teenagers and the third most common malignancy in children, accounting for 7.5% of all adoles-
cent cancers3. Because of the effects of radical surgery and chemotherapy, a significant reduction in the quality 
of life is found in children and adolescents. Moreover, for the last 20 years the 5-year survival has plateaued at 
approximately 70% and long-term complications of osteosarcoma survivors treated with intensive chemother-
apy have increased4. With the promising perspective of a new oncological therapy, cold atmospheric plasmas 
and plasma-activated liquids have come to the limelight. Cold atmospheric plasma (CAP) is an ionized gas at 
near-room temperature composed of a high number of reactive species, ions, electrons, metastable particles, elec-
tromagnetic field, and weak UV and VIS radiation. These plasma-generated reactive oxygen and nitrogen species 
(RONS), can be transferred to liquids through secondary reactions. Plasma-activated liquids display different bio-
logical actions which have been mainly attributed to the generation of RONS such as H2O2 5,6, NO2– 7, ONOO− 8, 
etc. These reactive species are known to be involved in a wide range of intracellular6,7,9 and intercellular pro-
cesses10 and have shown a strong anti-cancer effect on several cancer cell lines in vitro11–17 and on subcutaneously 
xenografted tumors in vivo14,17–21. Recently, proof of efficiency and selectivity in osteosarcoma was shown10,22–24. 
However, the exact mechanisms in OS remain to be elucidated. In other cancer types, it has been reported that 
CAP treatment induces an increase of intracellular ROS (reactive oxygen species) in cancer cells20,25 associated to 
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failures in antioxidant defenses26,27, DNA damage28,29, cell cycle arrest30,31 and apoptotic32 or necrotic33 cell death. 
Simultaneously, healthy cells show stronger resistance to CAP treatment34.
Besides, the effects of different plasma-activated liquids, including cell culture media, have been evaluated35. 
Following plasma treatment, these liquids are known as Plasma Activated Media (PAM) and have been shown to 
have cytotoxic effects on cancer cell cultures. As mentioned, one of the advantages commonly attributed to CAP 
is its antitumoral selectivity, without affecting healthy cells. CAP efficiency is based on the concentration and 
kind of RONS generated36,37. Exhaustive determination of all RONS present in PAM is far from straightforward, 
and the most often quantified species are hydrogen peroxide, nitrites and nitrates. It is known, however, that a 
much more complex cocktail of species is formed in PAM through diffusion from the gas phase to the liquid. It is 
claimed that this complex cocktail of RONS is the main responsible for the CAP-induced anticancer action38–40. 
The concentration and type of RONS depend enormously on plasma application parameters, such as distance or 
treatment time41, as well as on the chemical/biochemical composition of the liquid39,42.
So far, only a few works have addressed the differential effects of cold plasma on tumor and non-tumor cells 
using the same experimental settings24,36,40,43–46. In addition, previous reports tend to exclude sodium pyruvate 
(Pyr) from culture media formulations as it seems that this specific scavenger of H2O2 may reduce the efficiency 
of the plasma treatment in vitro25,47. However, Pyr is a key player on cancer metabolism and is commonly found 
in most cell culture media so this absence in CAP-related works deserves investigation. Adachi et al., showed that 
cell culture media composition determines PAM cytotoxic potential on cancer cells, and specifically Pyr reduces 
cell damage on cancer cells48. In other studies, Pyr has been successfully used to eliminate ROS induced angio-
genesis49 and proliferation50, by suppressing FGF2 release from plasma treated cells, suggesting that Pyr can affect 
intracellular and extracellular plasma effects.
Altogether, we aimed at defining the specific conditions in which CAP treatment shows a selective cytotoxic 
effect on tumor cells. Specifically, we focused on clarifying the role sodium pyruvate on modulating the concen-
tration of H2O2 and the selectivity of the anticancer effects of plasma-activated liquids. Different plasma treatment 
conditions of PAM (distance, gas flow, treatment time) with/without pyruvate were evaluated on the cytotoxicity 
of PAM, and mechanistic insights were investigated by studying cell proliferation, DNA damage, cell death mech-
anisms and cell signaling on osteosarcoma and non-cancer cells.
Results
Characterization of the plasma jet. An Atmospheric Pressure Plasma Jet (APPJ) was employed to treat 
cell culture media and obtain PAM (Fig. 1). Optical Emission Spectroscopy (OES) was used to analyze the species 
generated by plasma in gas phase (Fig. 1). OES reveals higher levels of nitrogen and oxygen radicals than excited 
helium atoms. The wavelengths 316, 337, 380, 706, and 777 nm were used to investigate production of *OH, N2 
2nd+, N2+ 1st−, He, and O*, respectively. Figure 1 reveals that higher gas flows (1 to 5 L/min) are accompanied by 
an increase in reactive species (N2+ 1st−, He and O*). The evolution of the peaks of the different plasma species 
with increasing flow rates (Table S1) showed a progressive increase of the N2+ intensity and slight increases for 
the rest of species.
Figure 1. Plasma jet generates reactive species in the gas phase. Main species detected by optical emission 
spectroscopy in the plasma gas phase at different gas flow rates (measured at 10 mm from the exit of the jet) 
(Left). Schematic illustration of the generation of PAM +/− Pyr with an APPJ. Parameters such as the gap 
between the plasma and the liquid surface (10 or 20 mm), or the gas flow (1, 3, 5 L/min) were investigated. 
DMEM was treated with APPJ to obtain PAM, which is then transferred onto cell cultures.
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Sodium pyruvate attenuates PAM cytotoxicity while increasing its antitumor selectivity. 
To investigate the anti-tumoral selectivity of PAM, its effect on viability of osteosarcoma SaOS-2 cells and 
healthy human Bone Marrow Mesenchymal Stem Cells (hBM-MSCs) was evaluated (Fig. 2). In the absence of 
pyruvate, plasma-activated DMEM efficiently eliminated cancer cells in all conditions after 24 hours of incuba-
tion with PAM. Although more resistant than OS cells, hBM-MSCs were also sensitive to PAM-Pyr treatment 
in a flow-dependent fashion. On the other hand, the presence of pyruvate resulted in a strikingly different effect 
of PAM in healthy and cancer cells. Thus, although significantly less efficiently than in the absence of pyruvate, 
PAM + Pyr treatment still induced a flow-dependent cytotoxic effect in SaOS-2 cells, whereas this treatment 
resulted in a flow-dependent increased proliferation of hBM-MSC, rather than in a cytotoxic effect (Fig. 2A).
Figure 2. Effects of PAM on osteosarcoma and healthy cells. (A) Effects of PAM +/− Pyr (1, 3 and 5 L/min 
helium flow at 10 mm gap) on cell viability were detected by WST-1 assay on hBM-MSCs and SaOS-2, measured 
24 h after exposure. Cell viability is expressed relative to the corresponding untreated control and is the mean 
and standard deviation of three independent experiments (*p < 0.05; **p < 0.005; two-sided Student’s t-test) 
(B) Effect of PAM +/− Pyr at different helium flows (1, 3 and 5 L/min) and 10 mm gap on the proliferation 
ability of hBM-MSCs healthy cells (left panel) and SaOS-2 cancer cells (right panel). We analyzed the 
Normalized Cell Index relative to treatment time (t = 0 h) up to final step (t = 70 h). Data are shown as the mean. 
Error bars represent the SD, and asterisks indicate statistically significant differences between the indicated 
series (*p < 0.05; **p < 0.01; two-sided Student’s t-test). Readings were done in duplicates.
4Scientific RepoRts |         (2019) 9:10681  | https://doi.org/10.1038/s41598-019-47128-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
To investigate this in depth, we performed a real-time proliferation assay by monitoring cell impedance up 
to 70 h post-treatment (Fig. 2B). Results confirm that cancer cells are much more sensitive to PAM treatment 
than healthy cells. Specifically, the treatment with a flow of 5 L/min in presence of Pyruvate results in a selective 
elimination of OS cells without affecting healthy hBM-MSC cells. The absence of pyruvate increases the cyto-
toxic potential of PAM in all the studied parameters. PAM-Pyr produces a decrease of proliferation in a gas flow 
dependent manner, both on osteosarcoma and healthy cells. This occurs disregard the medium where cells are 
grown prior to contact with PAM contains or not Pyr. Thus, while the cytotoxicity is not related to lack or shock 
of Pyr, it is true that cells grown in DMEM-Pyr are sensitive to treatment with PAM (Fig. S1). Conversely, in 
osteosarcoma cells PAM -Pyr leads to 0% viability and the total suppression of the proliferative capacity at all 
conditions evaluated (Fig. 2A,B). To further investigate the role of plasma-generated H2O2 in cytotoxicity, cata-
lase (Cat) was added to PAM immediately after treatment. As expected, catalase fully suppressed the cytotoxic 
potential of PAM in osteosarcoma cells (Fig. 3A). As observed in PAM-Pyr (Fig. 2A), PAM-Cat leads to a 70% 
reduction on SaOS-2 cell viability 4 h post-treatment and to 0% after 24 h. This can be attributed to the scavenging 
Figure 3. H2O2 scavengers protect osteosarcoma cells from PAM-induced apoptosis. (A) Effects of PAM +/− 
Cat activated during 5 minutes (3 L/min helium flow at 10 mm gap) were detected by WST-1 assay on SaOS-2, 
measured 2, 4 and 24 h after exposure. Catalase was added as control to untreated cell culture medium. Cell 
viability of Control + Cat, PAM + Cat and PAM-Cat is expressed relative to Control-Cat (untreated) and is the 
mean and standard deviation of three independent experiments (**p < 0.005; ***p < 0.001; two-sided Student’s 
t-test). (B) Concentration of NO2− and H2O2 in PAM+/-Catalase at different treatment times (1 to 5 min at 3 L/
min and 10 mm gap). Catalase addition to PAM, −not lead to significant differences on the concentration of 
NO2−, but reduces H2O2 concentration in all conditions studied. Data are presented as mean, n = 3, Error bars 
represent the SD, and asterisks indicate statistically significant differences between the PAM +/− Catalase series 
(**p < 0.01; ***p < 0.001; two-sided Student’s t-test). Concentration of RONS was measured immediately after 
APPJ treatments using untreated DMEM as blank. (C) SaOS-2 cells were treated with PAM + Pyr (top) and 
PAM-Pyr (bottom) activated by plasma at different Helium flows (1, 3 or 5 L/min) during 5 minutes. Apoptosis/
Necrosis activation were examined for Annexin V/PI binding using FACS analysis. PAM + Pyr at 1 L/min 
produces 2.6% apoptotic cells, progressively increasing with 3 L/min (5.5%) and to 5 L/min (29.8%). PAM-Pyr 
boosts these values, leading to 20% at 1 L/min, 89% at 3 L/min and 93% at 5 L/min of apoptosis positive cells 
Representative data at 24 hours are shown. Analysis were done in duplicates.
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of H2O2 by catalase which does not affect the generation of NO2− (Fig. 3B). To characterize the mechanism of cell 
death of SaOS-2 cells exposed to PAM +/− Pyr, activation of apoptosis or necrosis were analyzed by Annexin V/
PI staining after 24 h of treatment with PAM (Fig. 3C).
We found that PAM induced apoptosis (Annexin V positive cells) in SaOS-2 cells in a gas flow dependent 
manner in all the conditions studied, with only a marginal occurrence of other mechanisms of cell death such as 
necrosis (PI positive/Annexin V negative cells). Again, the induction of apoptosis is much more efficient in the 
absence of pyruvate reaching almost 90% of apoptotic cells after the treatment with plasma at 3 L/min, whereas 
the treatment in the presence of pyruvate produces approximately a 30% of apoptotic death after a 5 L/min treat-
ment. Similarly, in experiments where cells were treated with PAM + Pyr treated with 1 L/min of gas flow for 
different times we found a selective time-dependent induction of apoptosis in SaOS-2 cells but not in hBM-MSCs 
(Fig. 4A).
In addition, PAM treatment is able to induce DNA damage as seen by the increase of cells presenting γH2AX 
foci (Fig. 4B). In line with our findings in survival and apoptotic assays, treatment with PAM-Pyr induces sig-
nificantly higher levels of DNA damage than those achieved after the treatment with PAM + Pyr and the pres-
ence of pyruvate also determines that the genotoxic effect occurs specifically in OS cells and not in healthy cells 
(Fig. 4B,C). Altogether, PAM treatment efficiently induces apoptosis and DNA damage in OS cells and the pres-
ence or absence of pyruvate in its composition allows the modulation of its sensibility and selectivity.
Plasma-generated hydrogen peroxide is scavenged by pyruvate and its levels correlate with 
PAM induced cytotoxicity. While the increasing gas flow modifies only slightly the amount of species 
detected in the gas phase (Fig. 1), important variations might occur during treatment of liquids regarding the 
diffusion of species, or convection of the liquid. This is clearly shown by the amount of reactive species formed 
in PAM at different gas flows (Fig. 5), which has been evaluated at two different distances from the tip of the jet.
It is known that plasma generates long-lived reactive species such as H2O2 or NO2− (Fig. 5) in the treated 
liquids. Herein DMEM is evaluated, in the presence or absence of pyruvate. Pyruvate, is a component in some 
commercial formulations of cell culture media, and is also present naturally in the body. Its presence or absence 
in the PAM generates important differences with regard to the total reactive species and the hydrogen peroxide 
concentration. In PAM + Pyr we detected significantly lower concentrations of hydrogen peroxide, with differ-
ences ranging between 2 fold (5 L/min; 20 mm) and 15 fold (1 L/min; 10 mm) (Fig. 5A). In parallel, the amount 
of total ROS were up to 5 fold higher in PAM-Pyr (1 L/min; 10 mm) (Fig. 5B). The treatment distance does not 
significantly affect the level of total ROS generated in PAM-Pyr, which tends to decrease with the gas flow, and 
only at 1 L/min higher concentration is found at higher distance in PAM + Pyr. Opposite trend is observed in the 
concentration of H2O2, with concentration increasing with the gas flow and slightly higher amounts generated at 
longer distance both PAM +/− Pyr (Fig. 5A). The addition of this scavenger does not affect the concentration of 
NO2− (Fig. 5C), which is found maximum at short distance and gas flow (1 L/min, 10 mm), while relatively low 
concentrations are generated in all other conditions evaluated. Micromolar concentrations of NO2− and H2O2 are 
summarized on Table S2.
The concentration of H2O2 and of NO2− was quantified in 2 mL of DMEM with/without pyruvate treated with 
plasma at 1 L/min from 1 min up to 15 min with a gap of 10 mm. Data confirm that the generation of RONS in 
the cell culture medium following plasma treatment is time dependent (Fig. 5D). The presence of pyruvate in the 
medium does not lead to significant differences on the concentration of NO2−. However, the concentration of 
H2O2 generated in PAM after the treatment with plasma is highly influenced by presence of pyruvate, being up to 
100 times higher in the case PAM-Pyr media depending on the experimental conditions (Fig. 5D).
These results together with the cytotoxicity assays (Figs 2–4) show that CAP induced apoptosis in PAM-Pyr is 
related with an excess of lethal concentration of H2O2. Interestingly, the levels of NO2− in PAM-Pyr not be corre-
lated with the toxicity of the PAM.
pAM-pyr and H2o2 induce similar phosphorylation patterns in signaling kinases. To obtain an 
in-depth view of the regulation of PAM-dependent cell signaling, a Proteome Profiler Human Phospho-kinase 
Array was employed to analyze the changes in the kinase phosphorylation profile of SaOS-2 cells after the treat-
ment with PAM for 15 min. This treatment produced high NO2− and low H2O2 concentrations in DMEM + Pyr 
and high concentration of H2O2 and NO2− in DMEM - Pyr (Fig. 5D). Taking this into account, we used an equiv-
alent dose of H2O2 to PAM-Pyr (400 μM) to compare the effects of PAM and H2O2 on the phosphorylation profile 
(Fig. 6).
This study reveals a differential regulation in 13 of the 43 kinases analyzed. On the one hand, the presence of 
Pyr in PAM produces decreased phosphorylation of ERK1/2 (T202/Y204), GSK-3α/β (S21/S9), AMPKα1 (T183), 
CREB (S133), AMPKα2 (T172), FAK (Y397), P70 S6K (T421/S424) and STAT3 (Y705/S727) and increased phos-
phorylation of AKT (S473), C-JUN (S63), and HSP60. On the other hand, PAM-Pyr induces a general inhibitory 
effect of most of kinases which is greater than that observed after PAM + Pyr treatment. Relevant differences 
associated to absence of pyruvate include the inhibition, rather than activation, of AKT and C-JUN and highly 
increased phosphorylation levels of HSP60. Notably, SaOS-2 cells treated with H2O2 closely mimic the kinase 
phosphorylation profile of PAM-Pyr treated cells (Fig. 6A,B). Thus, the phosphorylation levels of 12 of the 13 
selected kinases were similarly increased or decreased in both treatments (Fig. 5C).
The similarity of the phosphorylation profiles induced by PAM-Pyr and H2O2 in relevant signaling kinases 
suggest that the increased levels of this ROS is a key mediator of the high cytotoxic effect induced by PAM in the 
absence of pyruvate and also that the differences observed after PAM-Pyr and PAM + Pyr treatments could be on 
the basis of the anti-tumor selectivity observed in the presence of pyruvate.
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Figure 4. PAM induces DNA damage and apoptosis mainly in OS cells. We used different treatment times (5, 
10 and 15 min) in PAM + Pyr at 1 L/min and 10 mm gap to analyze the cytoprotective effect of Pyr. (A) Analysis 
of apoptosis/necrosis by FACS using AnnexinV/PI on hBM-MSCs (top) and SaOS-2 (bottom). The percentage 
of apoptotic SaOS-2 on PAM + Pyr increases from the control (5.4%): 5 min (6.7%), 10 min (10.5%) and 15 min 
(19.2%). Representative data at 24 hours are shown. Analysis were done in duplicates. (B) Representative 
images (left) and quantification (right) of immunofluorescence for γH2AX (Green) and DAPI (blue) after 2 h 
on (B) SaOS-2 and (C) hBM-MSCs treated with PAM +/− Pyr at 1 L/min and 10 mm for 10 min. Quantitative 
analysis are shown as percentage of γH2AX positive (green) vs the total number of DAPI (blue) positive nuclei 
at the indicated treatment times. PAM +/− Pyr on SaOS-2 induces no statistically significant differences exist 
at 10 (p value = 0.1573) and 15 min (p value = 0.008), showing only significant differences on 5 min treatment 
time (p value = 0.0008). PAM -Pyr is capable to affect DNA integrity on healthy cells (p value = 0.0002). Scale 
bar = 50 µM. Data are presented as mean, n = 3. Error bars represent the SD, and asterisks indicate statistically 
significant differences between the PAM +/− Pyr series (*p < 0.05; **p < 0.01, ***p < 0.001; two-sided 
Student’s t-test).
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Discussion
CAP has been suggested as a new therapy against cancer41,51, but its selectivity against cancer cells avoiding dam-
age to healthy cells has been less investigated, as only around 30% of the published research reports selectivity. It 
has been described that it is possible to take advantage of the biological differences between cancer cells and nor-
mal cells to selectively kill the malignant cells. The disparities in ROS production and metabolism in cancer cells 
versus normal cells provides a biochemical basis to develop new therapeutic strategies to preferentially increase 
ROS to a toxic level in cancer cells. A “threshold concept” for cancer therapy has been proposed to explain the 
dual effects of oxygen radicals52. In cancer cells, if ROS levels reach the “threshold level” that overwhelms the 
antioxidant capacity, irreversible damage occurs and apoptosis is initiated, and as observed here, this threshold 
level is different for cancer and healthy cells.
In this work we employ an atmospheric pressure plasma jet (APPJ)22 to evaluate suitable treatment conditions 
to selectively damage SaOS-2 osteosarcoma cells, without affecting healthy hBM-MSCs. The first aim was to 
determine the relationship between the concentrations of plasma generated-RONS in PAM at different plasma 
treatment conditions with anti-osteosarcoma selectivity. This is intended to help answering the question of which 
of the plasma generated RONS is more relevant with regard the anti-tumoral selectivity of APPJ. To that aim, 
different parameters were modified during CAP treatment of DMEM: i. Distance to the liquid surface (10 or 
20 mm); ii. Gas flow (1, 3, 5 L/min) and iii. Treatment time (1 to 15 min). DMEM cell culture medium with or 
without addition of sodium pyruvate was employed to investigate the specific role of H2O2 in the biological effects 
of PAM on osteosarcoma in vitro.
APPJ-treated PAM–Pyr was completely cytotoxic to SaOS-2 cells, decreasing hBM-MSC viability between 
80 and 20% (Fig. 2A) and proliferation (Fig. 2B) in a gas flow dependent manner. This toxicity was partially 
abrogated in SaOS-2 in presence of pyruvate and even proliferation was stimulated in SaOS-2 (1 L/min, 10 mm) 
and hBM-MSC (Fig. 2B). Surprisingly, pyruvate effectively reduces PAM-induced apoptosis in OS (Fig. 3) and 
prevents apoptosis in healthy cells (Fig. 4A).
Due to the capacity of CAP to generate RONS, we evaluated its genotoxic potential by analyzing the levels 
of γH2AX. In our study, CAP-treated medium induced an increase in the level of γH2AX under all tested treat-
ment conditions, with higher values after PAM-Pyr treatment (Fig. 4B,C). The decrease in γH2AX recorded after 
Figure 5. Profile of RONS on PAM depends on various APPJ operating parameters. Different physical 
parameters like the gap between APPJ nozzle to cell culture surface (10 or 20 mm), Helium Flow (1, 3, and 
5 L/min) and treatment time (5 min) were used to obtain 2 mL of PAM +/− Pyr. (A) Micromolar (μM) 
concentration of Hydrogen Peroxide (H2O2) by AmplexRed/HRP assay. (B) ROS were measured by DCF-DA 
fluorescence intensity (x103). (C) Micromolar (μM) concentration of Nitrites (NO2−) by Griess assay. (D) 
Concentration of NO2− and H2O2 in PAM +/− Pyr at different treatment times (1 to 15 min at 1 L/min and 
10 mm gap). PAM + Pyr not lead to significant differences on the concentration of NO2−, with a maximum of 
341 ± 27 µM (PAM + Pyr) or 299 ± 10 µM (PAM-Pyr). Data are presented as mean, n = 3, Error bars represent 
the SD, and asterisks indicate statistically significant differences between the PAM +/− Pyr series (*p < 0.05; 
**p < 0.01; ***p < 0.001; two-sided Student’s t-test). Concentration of RONS was measured immediately after 
APPJ treatments using untreated DMEM as blank. The exact concentrations of RONS are presented in Table S2.
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PAM + Pyr treatment suggests that H2O2 plays a pivotal role in the DNA damage induced by CAP. However, 
PAM + Pyr did not fully prevent the presence of γH2AX foci (Fig. 4B,C), so in line with previous works32 our 
results suggest that other plasma-generated RONS may be also activating DNA damage response. An important 
asset is that DNA damage is found preferably in SaOS-2 cells treated with PAM +/− Pyr (Fig. 4B,C). This, in con-
junction with the fact that healthy cells do not enter in apoptosis (Fig. 4A), seems to indicate that PAM induces 
apoptosis and DNA damage mainly in osteosarcoma cells, but the absence of pyruvate increases the DNA dam-
age, affecting both healthy and tumor cell lines (Fig. 4B,C). In hBM-MSCs, higher γH2AX levels after PAM-Pyr 
treatment (Fig. 4C) correlate with a decreased cell viability and proliferation (Fig. 2).
The involvement of RONS generated by plasmas in cell culture media in the anticancer effects of PAM has 
been reported in many studies, with special emphasis on the role of H2O2 and NO2−, among other species36,40. 
Many other studies suggest that H2O2 is the most relevant ROS from CAP in views of tumor cell killing6,39,40,53. 
Beckeschus et al. showed that the enzyme catalase very effectively suppressed the cytotoxic effects of PAM medi-
ated by H2O2 54,55. In this regard, our data show the same trend, the presence of scavengers such as Pyr or catalase, 
efficiently nullifies the cytotoxic potential of PAM (Fig. 3). In line with these data, it is reasonable to postulate that 
the sensitivity found in cells may be due to an excess of H2O2 when used in PAM-Pyr.
The gas phase of the plasma jet evaluated here contains several radical and ionic species (O*, *OH, N2+) 
(Fig. 1) which vary in concentration depending on treatment conditions such as the flow of the gas (He) employed 
Figure 6. OS cells phosphorylation profiling affected by PAM. Phospho-kinase antibody array showing 
the phosphorylation/activation status of a panel of kinases in SaOS-2 cells after treatment with PAM +/− 
Pyr (10 mm, 1 L/min, 15 min) or H2O2 (400 μM) for 6 hours. (A) Representative spots and numbers listed 
correspond to 13/43 selected kinases. (B) Selected spots were digitized and mean pixel intensity is presented 
as columns (untreated) or colored markers (treatments). (C) Venn diagram illustrating the number of similar 
phosphorylation pattern between treatments PAM + Pyr (blue), PAM-Pyr (red) and H2O2 (yellow): PAM + Pyr 
& PAM-Pyr (2/13), PAM + Pyr & H2O2 (0/13), PAM-Pyr & H2O2 (12/13). Complete images of the phospho-
kinase antibody array are presented as Fig. S2.
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to generate the discharge (Table S1). This and other parameters which modify the gas phase discharge, certainly 
influence on the amount of RONS formed in the cell culture medium due to plasma CAP treatment. Here, H2O2, 
NO2− and total Reactive oxygen species (ROS) were quantified in PAM (Fig. 5). At short distance between the jet 
and the liquid surface, high NO2− concentration is produced, deriving from NO2 dissolution from the plasma gas 
phase, especially at low gas flow35. As shown by Lu et al. [76] the amount of N in the effluent of a jet can be of 10 
orders of magnitude higher at 10 mm than at 20 mm, coping well with these results.
Also, higher electron density may happen near the surface at shorter distances, leading to enhanced reactivity 
with the liquid; at higher gas flows increased water vapor mixing with the jet leads to higher H2O2 concentrations, 
etc. The basics of reactivity of plasmas with liquids have been summarized elsewhere35. The species measured in 
this work are an example of some of the many RONS that may be formed in CAP treated liquids. Other species 
that we could assume to be present in our PAM are NO3− which is often quantified in saline solutions56,57, or cell 
culture media42, *OH that was observed in aqueous solution by electron paramagnetic resonance (EPR)58, or 
ONOO− which is known also to be of importance in biological processes but not straightforward to measure in 
liquids.
In other works, NO2− and H2O2 concentrations have shown a synergistic cytotoxic effect in PAM40. In our 
case, at 1 L/min we obtain the highest concentrations of nitrites (Fig. 5C), but an increase in the proliferation 
of hBM-MSCs and SaOS-2 is observed (Fig. 2A,B). In addition, PAM + Pyr activated at 1 L/min during 15 min 
(Fig. 4A) has less apoptotic potential than a 5 min-treatment with PAM-Pyr (Fig. 3). Furthermore, pyruvate sig-
nificantly reduces the concentration of H2O2 (Fig. 5D). Therefore, our data reveal that PAM-Pyr induced apopto-
sis in OS cells is mainly related to H2O2 concentration. Thus, in line with other works36,38,40, SaOS-2 cells display 
APPJ-treatment time dependent apoptosis (Fig. 4A). However, the fact that PAM + Pyr with low H2O2 concen-
tration can induce apoptosis in a gas flow (Fig. 3) and treatment time dependent manner (Fig. 4A), suggest that 
other RONS formed in PAM and not studied in this work could be acting on plasma induced cell toxicity. In any 
case, in PAM-Pyr we obtained enough H2O2 concentration to induce apoptosis (Fig. 5A–D & Table S2).
Our results reflect on the important effect of sodium pyruvate, which abolishes the cytotoxic potential of 
PAM by increasing cell proliferation and reducing the levels of apoptosis induced by PAM on osteosarcoma 
cells with respect to PAM-Pyr. Furthermore, absence of Pyruvate increases the efficacy of PAM in cancer and 
healthy cells, eliminating the anti-tumoral selectivity. This can be directly related to high H2O2 concentrations. 
These results can be explained considering two aspects of pyruvate: i. Its scavenging properties as it reacts with 
H2O2 to produce CO2, H2O and acetate through an oxidative decarboxylation59,60, ii. Its biological effects: Pyr 
protects cells from H2O2 cytotoxicity by mitochondrial regulation, especially if the ROS are generated in cell 
culture medium61–63, and iii. Pyr protects cells by activating Akt signaling pathway and increasing defenses to 
H2O2 like glutathione peroxidase activity64. To this regard, many studies defend that CAP produces its cytotoxic 
effects through a reduction of antioxidant defenses such as glutathione peroxidase27, or through depolarization of 
the mitochondrial membrane5,25. Thus, it is clear that pyruvate is a relevant player to take into account to address 
CAP efficiency.
We have shown that cytotoxic effects of PAM in our experimental setting are related mainly to the concen-
tration of H2O2. This is further confirmed by the fact that PAM-Pyr generates a phosphorylation profile very 
similar to that obtained after treatment with H2O2 (Fig. 6). The less effective treatment in inducing apoptosis 
(PAM + Pyr) produces signals related to sublethal levels of oxidative stress and proliferation such as c-JUN65 and 
AKT64. It should be underlined that treatment with PAM (+/− Pyr) as well as with H2O2, affects proteins related 
to mitochondrial stress and apoptosis like HSP6066, or STAT3 pathway67. This is in line with previous results relat-
ing the cytotoxic activity of PAM with an increase in mitochondrial damage6,25,47,68. These three treatments affect 
cell signaling related to autophagy like STAT3 and AMPKα1/AMPKα2. Furthermore AMPK inhibition increases 
chemo-sensitivity69 and STAT3 downregulation suppresses osteosarcoma cell growth and induces apoptosis70. 
Furthermore, only treatment with PAM (+/− Pyr) affects FAK activation, a kinase associated to cell invasion 
and poor prognosis in sarcoma71. All this confirms that PAM may have therapeutic potential in the treatment of 
osteosarcoma.
While other studies have described that the anti-tumor selectivity of CAP depends on the activation of p53 
and ERK47,68, our data in SaOS-2 cells (P53 null)72 indicate that p53 (S46) is not related to PAM cytotoxicity 
(Fig. S2), while ERK is downregulated (Fig. 6). In general, H2O2 affects the same molecular targets than PAM-Pyr 
in a total of 12/13 of the altered kinases. The signaling affected by PAM seems to depend on the concentration of 
reactive species and may be related to an adaptive response to oxidative stress, although a more thorough study 
would be recommended.
Our data show that PAM-Pyr has greater cytotoxic effect accompanied with a loss of anti-tumor selectivity. 
This is a clear indication that the selectivity of PAM in vitro is H2O2-dependent. In the clinical setting, other liquid 
media such as saline solutions are expected to be employed to deliver RONS from plasmas rather than PAM, so 
different concentrations of RONS may be expected. Nevertheless, this work is relevant because Pyr is found in the 
tumoral environment, and as described here, it may enormously modify the cytotoxic effect of plasma-activated 
saline solutions when injected in vivo. It is therefore necessary to take into account all components in the cancer 
environment to propose relevant in vitro studies and obtain a correct in vivo plasma application targeting only 
cancer cells.
While we have shown that concentration of H2O2 has a high impact on selectivity, there are many stud-
ies describing the anti-carcinogenic effects of CAP by many other reactive species such as O2−, OH*, NO, O, 
NO3−, NO2− and ONOO− 73. However, when using PAM or saline solutions activated by plasma35,74, usually only 
H2O2 41,48,75,76 or NO2− 38,40 are determined due to their long life and easier detection methods available. As men-
tioned above for the case of Pyr, in the clinical application, RONS generated by plasma may not be present in same 
concentrations as those determined in liquids such as PAM because other factors can interfere with the formation 
and stability of RONS e.g. proteins, organic and inorganic molecules etc.
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Therefore, it can be inferred that to investigate the antitumor selectivity of CAP in vitro, PAM should be 
obtained in conditions leading to an “equilibrated” cocktail of RONS, and not only an excess of H2O2.
Methods
Plasma jet device. An atmospheric pressure plasma jet (APPJ) was created using Helium (5.0 Linde, Spain) 
as plasma gas in a jet design with a single electrode as described elsewhere77. The electrode was connected to a 
commercial high voltage power supply from Conrad Electronics (nominally 6 W power consumption). The dis-
charge was operating with sinusoidal waveform at 25 kHz with (U) ~ 2 kV and (I) ~ 3 mA. He flow in the capillary 
was regulated between 1 and 5 L/min through a MassView flow controller (Bronkhorst, Netherlands).
Optical emission spectroscopy (OES). OES was used to determine the main plasma emitting species. 
The equipment used was a spectrometer F600-UVVIS (StellarNet, Tampa, FL, USA), which was connected to an 
optical fiber with lens that collected information from the measure point near the plasma jet. For data processing 
the SpectraWiz software (StellarNet, Tampa, FL, USA) was used. The optical fibre was placed perpendicular to 
the jet and measurements were made about ten millimetres below the beginning of the jet (in the post-discharge, 
d = 10 mm). All results were obtained with an integration time of 1000 ms and an average of 10 scans.
Plasma activated medium (PAM). We studied the concentration of RONS and cellular responses gen-
erated after APPJ treatments on 2 mL DMEM, high glucose, no glutamine, no phenol red (GibcoTM, cat.no 
31053028, Carlsbad, CA, USA) with or without 0.1 g/L Sodium Pyruvate (GibcoTM, cat.no 11360070, Carlsbad, 
CA, USA) in a 24-well plate. Catalase (MP Biomedicals™, cat.no 9001-05-2) was added at 20 μg/mL immediately 
after (within 5 s) after plasma treatments, prior to putting it in contact with cells.
Three APPJ parameters were varied: 1. He flow rate: 1, 3 and 5 L/min; 2. Gap between APPJ nozzle and DMEM 
Surface: 10 or 20 mm; 3. Treatment time: between 1 and 15 min.
Concentration of RONS in PAM. Nitrites. Determination of NO2− concentration in PAM was performed 
using Griess reagent78. The Griess working solution used was obtained by dissolving 1% wt/v of sulphanilamide, 
0.1% wt/v of NEED and 5% w/v of phosphoric acid in de-ionized water. 50 μL of Griess solution were added on 
50 μL of sample in 96 well-plates. The plates were incubated for 10 min at room temperature protected from light. 
The absorbance was measured at λabs = 540 nm using a Synergy HTX Hybrid Multi Mode Microplate Reader 
(BioTek Instruments, Winooski, Vermont, USA). The [NO2−] in each sample was determined from the absorb-
ance values by using a calibration curve made from a commercial standard Sodium Nitrite 14 mM (CellBiolabs, 
cat.no 280201, San Diego, CA, USA) diluted on DMEM.
Hydrogen peroxide. The concentration of hydrogen peroxide was determined by Amplex™ Red Hydrogen/HRP 
Peroxide Kit (cat.no A2218, Invitrogen, Carlsbad, CA, USA) following the manufacturer’s protocol. Since the 
higher concentration of H2O2 able to be processed properly by this reagent is around 5 µM of H2O2, PAM with 
sodium pyruvate were diluted 10 and PAM without sodium pyruvate were diluted 10–100 times previously to the 
addition of the reagent. In this case, for hydrogen peroxide detection, 50 μL of the AmplexTM Red/Horseradish 
Peroxidase (HRP) reagent were added to 50 μL of PAM in a dark 96-well plate and incubated for 30 min at room 
temperature. Subsequent fluorescence measurements were performed by means of a Synergy HTX Hybrid Multi 
Mode Microplate Reader (BioTek Instruments, Winooski, Vermont, USA), with fluorescence filters centred at 
λex = 560/20 nm and λem = 590/20 nm as excitation and emission wavelengths, respectively. Concentrations of 
H2O2 in PAM generated by plasma treatment were obtained from fluorescence values using a calibration curve 
following the manufacturer’s protocol.
Generation of total ROS. Total ROS were determinated by a fluorescence method using 2′,7′ Dichlorodihydr- 
ofluorescein diacetate (DCFH-DA), used as scavenger of ROS in liquid media (Sigma-Aldrich, cat.no D6883, Sant 
Luois, MO, USA). DCFH was added to 150 μL PAM in proportion 1 μL of 2 mM 2,7-DCHF for of PAM in a dark 
96-well plate. After 30-min incubation at room temperature, fluorescence intensity was read with a Synergy HTX 
Hybrid Multi Mode Microplate Reader using λex = 485/20 nm and λem = 528/20 nm as excitation and emission 
wavelength filters, respectively.
Cell culture. We evaluated the effects of PAM on the osteosarcoma cell line SaOS-2 and healthy Human Bone 
Marrow Mesenchymal Stem Cells (hBM-MSCs) (both cell types obtained from ATCC, USA). In this study cell 
lines were grown in Dulbecco’s Modified Eagle Medium (DMEM) with glucose (4,5 g/L), pyruvate, no glutamine 
(Gibco™ cat no. 21969035, Carlsbad, CA, USA), to which we add 10% fetal bovine serum (FBS) (Gibco™ cat no. 
10270098, Carlsbad, CA, USA), 2mM L-glutamine (Gibco™, cat.no 25030081), 100 units/mL penicillin (Gibco™, 
cat.no 15140122) and 100 µg/mL streptomycin (Gibco™, cat.no 15140163). The cells were incubated at 37 °C, 95% 
humidity and 5% CO2.
Cell viability assay. To evaluate the antitumor effects of PAM treatment, a WST-1 (Roche, cat.no 05015944001, 
Mannheim, Germany) cell proliferation assay was performed according to the manufacturer’s instructions. Cells 
were seeded in a 96-well plate at a density of 5 × 103 per 1000 μL of culture medium. On the following day, the cul-
ture medium was replaced with 150 μL of PAM. After 24 hours, WST-1 working solution (18 μL/mL) was added 
to each well and plates were incubated at 37 °C for 60 min. Absorbance was measured at λabs = 440 nm. Each 
experiment was performed by independent triplicates. Cells untreated by PAM were used as control.
Proliferation analysis. To evaluate long-time PAM effects on proliferation ability we used the xCELLigence sys-
tem (ACEA Biosciences, Inc, San Diego, CA, USA)79. Cells were seeded in specially designed microtiter plates 
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containing interdigitated gold microelectrodes at a density of 10 × 103 per 500 μL of culture medium. On the 
following day, 400 μL of culture medium was replaced with 400 μL of PAM. The continuous cell impedance non-
invasive monitoring by the xCELLigence system was measured every hour until the end of experiment (70 h 
post-treatment).
Analysis of apoptosis/necrosis activation. Cells were seeded on 6-well plate at a density of 50 × 103 per 1000 μL 
of culture medium, on the following day, the culture medium was replaced with 1500 μL of PAM. After PAM 
treatment on indicated conditions, cells were stained with Dead Cell Apoptosis Kit with Annexin V Alexa Fluor™ 
488 & Propidium Iodide (PI) (Invitrogen, cat.no 10257392, Carlsbad, CA, USA) following the manufacturer’s 
protocol. Cell counts were determined by flow cytometry, and data analysis was performed with FlowJo Software 
(https://www.flowjo.com/).
DNA damage. Cells were seeded on 8-well chamber slides at a density of 15 × 103 per 500 μL of culture medium, 
on the following day, the culture medium was replaced with 400 μL of PAM. After PAM treatment on the indi-
cated conditions cells were fixed with 4% paraformaldehyde in PBS for 15 min, washed three times with PBS, and 
permeabilized with 0.1% Triton X-100 on ice for 5 min. They were washed three times with PBS and blocked with 
SuperBlock™ (TBS) (ThermoScientific, cat.no 37535, Carlsbad, CA, USA) during 1 h. Cells were stained over-
night at 4 °C on rocking platform for Anti-phospho-Histone γH2AX (Ser139) mouse Antibody, clone JBW301 
(Merk Millipore, cat no. 05-636, Burlington, MS, USA) using a dilution 1:500. Following staining, cells were 
washed three times with PBS and incubated for 1 h at room temperature with Goat Anti-Mouse IgG H&L (Alexa 
Fluor® 488) (Abcam, ab150113, Cambrigde, UK). Samples were washed three times with PBS, and mounted 
using ProLong® Gold antifade with DAPI (LifeTechnologies, cat no. P36931, Carlsbad, CA, USA), be imaged 
with a Zeiss laser scanning microscope. Immunofluorescence images were taken at 25x.
Human proteome profiler array. The phosphorylation profile was analyzed in the PAM treated cells using the 
Proteome Profiler Human Phospho-Kinase Array (R&D Systems, cat.no ARY003B, Minneapolis, MN, United 
States). Cells (1 × 106) were plated in a 100-mm dish, on the following day, the culture medium was replaced with 
8000 μL of the indicated treatments (Fig. 6). 6 h post-treatment cells were collected by scraping. 300 μg total pro-
tein were applied per array set comprised of two nitrocellulose membranes with the spotted capture antibodies. 
The bound material was detected using the biotinylated antibodies followed by streptavidin conjugated with HRP. 
Chemiluminiscence was detected using Odyssey Fc imaging system and the software Image Studio from LI-COR 
(Lincoln, NE, USA). The pixel density of the background was substracted from the signal of each spot, and the 
average of duplicate spots was determined using the ImageJ software.
Statistical analysis. All data are presented as means ± SD. Statistical analysis of the data was performed 
using a Student’s t-test. p-values < 0.05 were considered statistically significant.
Conclusion
Overall, this work shows that the reactive species generated by CAP determine the selective anti-tumoral poten-
tial of PAM. The concentrations of RONS depend on the plasma process parameters and largely on culture media 
formulation. Our results reveal that sodium pyruvate plays a pivotal role on cold atmospheric plasma application 
in cancer treatment; On the one hand pyruvate diminish the cytotoxic potential of PAM both in cancer and 
especially healthy cells, thus enabling the possibility of finding a therapeutic window and selectively eliminat-
ing cancer cells. On the other hand, absence of pyruvate increases effects of PAM through a H2O2 dependent 
mechanism in cancer and non-cancer cells, resulting in a loss of anti-tumor selectivity. Regardless of pyruvate, 
PAM produces inhibition of relevant kinases such as AMPK or STAT3, thus revealing itself as a potential therapy 
against osteosarcoma.
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